Hadassah

Hadassah Ophthalmology Department Research Highlighted by JAMA

Tuesday, Jun 12 2018

Thanking the Hadassah Medical Organization’s researchers for their ”excellent submission” to JAMA Ophthalmology regardinga multi-center international study of the variable effectiveness of treatment for neovascular age-related macular degeneration (nAMD),the editors explained that their article was one of just a few from 12 JAMA on-line journals to be highlighted in The JAMA Network Reader this weekend.

The Reader is available free to everyone around the world at http://app.jamanetwork.com.

Prof. Itay Chowers, head of Hadassah’s Department of Ophthalmology, and Michelle Grunin, a PhD student of his at the time, conducted this study in collaboration with colleagues in Australia, Canada, Germany, the Netherlands, Northern Ireland, Norway, Switzerland, United Kingdom, and the United States. Together, they identified genetic factors that are associated with variability in response to a particular type of therapy for patients with nAMD, where abnormally high levels of vascular endothelial growth factor (VEGF) are secreted in the eyes, promoting the growth of new abnormal blood vessels. Anti-VEGF injection therapy blocks this growth.

The authors’ findings led them to propose that “there is a limited contribution of common genetic variants to variability in nAMD treatment response. Our results suggest that rare protein-altering variants in the C10orf88 and UNC93B1 genes are associated with a worse response to anti-VEGF therapy in patients with nAMD, but these results require further validation in other cohorts.”

Read the full article in JAMA Ophthalmology.

Related Stories

alt_text

Monday, Jun 29 2020

COVID-19 Nursing Care Leads to Collaborative Research by Hadassah Nurses

With a little distance from the first phase of the COVID-19 pandemic, Hadassah Medical Organization nurse educator and critical care specialist Julie Benbenishty...

READ MORE ›
alt_text

Monday, Jun 29 2020

First Commercial Antibody Serum Given at Hadassah to COVID-19 Patient

The Hadassah Medical Organization worked with an ultra-Orthodox communal organization to collect antibody-rich plasma from recovered COVID-19 patients...

READ MORE ›
alt_text

Thursday, Jun 25 2020

A Family Legacy Continues at Hadassah Hospital Mount Scopus

When New Jersey-born book publicist Jessica Singer married Yehoshua Freud, a computational chemist last August...

READ MORE ›
alt_text

Wednesday, Jun 24 2020

“Failure to Thrive” Infant Diagnosed by Hadassah Specialists

Hannah Finkelstein* had nursed her three older children, all healthy and inquisitive youngsters. So when baby Leah, only 4 days old, was losing weight...

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Israel Travel

israeltravel@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More